A detailed history of Robertson Stephens Wealth Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Robertson Stephens Wealth Management, LLC holds 32,018 shares of ABBV stock, worth $5.62 Million. This represents 0.23% of its overall portfolio holdings.

Number of Shares
32,018
Previous 25,695 24.61%
Holding current value
$5.62 Million
Previous $4.41 Million 43.45%
% of portfolio
0.23%
Previous 0.23%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $1.04 Million - $1.26 Million
6,323 Added 24.61%
32,018 $6.32 Million
Q2 2024

Aug 13, 2024

BUY
$154.79 - $180.76 $183,426 - $214,200
1,185 Added 4.83%
25,695 $4.41 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $500,716 - $570,519
3,133 Added 14.66%
24,510 $4.46 Million
Q4 2023

Feb 06, 2024

SELL
$137.6 - $154.97 $39,628 - $44,631
-288 Reduced 1.33%
21,377 $3.31 Million
Q3 2023

Nov 13, 2023

BUY
$133.59 - $154.65 $33,397 - $38,662
250 Added 1.17%
21,665 $3.23 Million
Q2 2023

Aug 11, 2023

BUY
$132.51 - $164.9 $625,049 - $777,833
4,717 Added 28.25%
21,415 $2.89 Million
Q1 2023

May 11, 2023

BUY
$144.61 - $166.54 $178,304 - $205,343
1,233 Added 7.97%
16,698 $2.66 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $16,873 - $20,236
-122 Reduced 0.78%
15,465 $2.5 Million
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $282,914 - $324,484
-2,108 Reduced 11.91%
15,587 $2.09 Million
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $140,234 - $178,284
1,019 Added 6.11%
17,695 $2.71 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $255,117 - $316,528
-1,933 Reduced 10.39%
16,676 $2.7 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $1.04 Million - $1.32 Million
9,685 Added 108.53%
18,609 $2.52 Million
Q3 2021

Nov 10, 2021

SELL
$106.4 - $120.78 $186,732 - $211,968
-1,755 Reduced 16.43%
8,924 $962,000
Q2 2021

Aug 17, 2021

BUY
$105.21 - $117.21 $33,141 - $36,921
315 Added 3.04%
10,679 $1.2 Million
Q1 2021

May 07, 2021

BUY
$102.3 - $112.62 $80,305 - $88,406
785 Added 8.2%
10,364 $1.12 Million
Q4 2020

Feb 10, 2021

BUY
$80.49 - $108.67 $125,081 - $168,873
1,554 Added 19.36%
9,579 $1.03 Million
Q3 2020

Nov 10, 2020

SELL
$85.91 - $100.83 $134,706 - $158,101
-1,568 Reduced 16.35%
8,025 $702,000
Q2 2020

Aug 12, 2020

SELL
$73.37 - $98.18 $227,447 - $304,358
-3,100 Reduced 24.42%
9,593 $941,000
Q1 2020

May 01, 2020

BUY
$64.5 - $97.79 $361,780 - $548,504
5,609 Added 79.18%
12,693 $967,000
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $467,330 - $584,729
-6,479 Reduced 47.77%
7,084 $627,000
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $854,197 - $1.03 Million
13,563 New
13,563 $1.03 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $311B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Robertson Stephens Wealth Management, LLC Portfolio

Follow Robertson Stephens Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robertson Stephens Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Robertson Stephens Wealth Management, LLC with notifications on news.